OPK
OPKO HEALTH, INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.75
−1.13%Price chart
Oct 7Oct 12Oct 15Oct 20Oct 23Oct 28Nov 2Nov 5
Key dataNov 5, 2026
Open$1.71
From 52W high−1.13%
Volume8.82M
Market cap$1.30B
P/E (TTM)—
P/S (TTM)2.6x
Div yield—
Key dataNov 5, 2026
Open
$1.71
From 52W high
−1.13%
Volume
8.82M
Market cap
$1.30B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−17.2x
P/E (TTM)
—
RSI (14)
64.2
MomentumView details →
1D Return
−1.13%
YTD Return
+38.90%
SummaryUpdated Sep 1, 2026
OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company founded in 1991 and headquartered in Miami, Florida. The company went public in 1995 and operates through two primary business segments: diagnostics and pharmaceuticals. OPKO has evolved from a traditional pharmaceutical company into a broader healthcare enterprise that combines laboratory testing services with drug development and commercialization. The company operates internationally across the United States, Ireland, Chile, Spain, Israel, and Mexico, serving healthcare providers, patients, and pharmaceutical partners through its integrated platform of diagnostic services and therapeutic products.
Similar companies
Latest newsMore news →
OPKO HEALTH, INC. reported a third-quarter loss of $0.05 per share, compared with a consensus estimate of a $0.07 loss and earnings of $0.03 per share a year earlier.21h agoOPKO Health reported its business highlights and financial results for the third quarter ended September 30, 2026.1d agoOPKO Health entered into an agreement with LABCORP HOLDINGS INC. to sell substantially all of its remaining BioReference Health diagnostic operations.1d ago